Ostrowski; Jacek

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ostrowski; Jacek.The latest application filed is for "novel use of a formyl peptide receptor 2/ lipoxin a4 receptor (fpr2/alx) agonist for treatment of heart failure".

Company Profile

1.6.17

Ostrowski; Jacek - Jamison NJ
Ostrowski; Jacek - Encinitas CA
Ostrowski; Jacek - Goleta CA
Ostrowski; Jacek - Santa Barbara CA
Ostrowski; Jacek - Oceanside CA
Ostrowski; Jacek - Getzville NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Use Of A Formyl Peptide Receptor 2/ Lipoxin A4 Receptor (fpr2/alx) Agonist For Treatment Of Heart Failure App 20200069644 - Ostrowski; Jacek ; et al.	2020-03-05
Targeting Of The Formyl-peptide Receptor 2/lipoxin A4 Receptor (fpr2/alx) For Treatment Of Heart Disease App 20180325869 - Ostrowski; Jacek ; et al.	2018-11-15
Methods And Compositions For Controlling Assembly Of Viral Proteins App 20150252081 - de los Rios; Miguel A. ; et al.	2015-09-10
Methods and compositions for controlling assembly of viral proteins Grant 8,865,188 - de los Rios , et al. October 21, 2	2014-10-21
Self-assembling Nanoparticle Drug Delivery System App 20140010885 - de los Rios; Miguel ; et al.	2014-01-09
Methods And Compositions For Controlling Assembly Of Viral Proteins App 20130156818 - de los Rios; Miguel ; et al.	2013-06-20
Chimeric Therapeutics, Compositions, And Methods For Using Same App 20110293727 - de los Rios; Miguel ; et al.	2011-12-01
Chimeric Therapeutics, Compositions, And Methods For Using Same App 20110293725 - de los Rios; Miguel ; et al.	2011-12-01
Chimeric Therapeutics, Compositions, And Methods For Using Same App 20110293726 - de los Rios; Miguel ; et al.	2011-12-01
Compositions and methods for treating B-cell malignancies Grant 8,067,011 - Davis , et al. November 29, 2	2011-11-29
White electrophosphorescence from semiconducting polymer blends Grant 7,830,085 - Gong , et al. November 9, 2	2010-11-09
Vitamin enriched snack chips App 20100062125 - Ostrowski; Jacek ; et al.	2010-03-11
Self-assembling nanoparticle drug delivery system App 20090226525 - de los Rios; Miguel ; et al.	2009-09-10
Compositions and methods for treating B-cell malignancies App 20070269370 - Davis; Claude Geoffrey ; et al.	2007-11-22
Plasmon assisted enhancement of organic optoelectronic devices Grant 6,999,222 - Bazan , et al. February 14, 2	2006-02-14
White electrophosphorescence from semiconducting polymer blends App 20050073245 - Gong, Xiong ; et al.	2005-04-07
Plasmon assisted enhancement of organic optoelectronic devices App 20050035346 - Bazan, Guillermo C. ; et al.	2005-02-17
Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements App 20040068762 - Attar, Ricardo M. ; et al.	2004-04-08
Therapeutic combinations of RAR antagonists and RXR agonists and use thereof Grant 6,653,322 - Chambon , et al. November 25, 2	2003-11-25
Cell lines and cell-based assays for identification of androgen receptor modulators App 20020058290 - Ostrowski, Jacek ; et al.	2002-05-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.